Fri, Aug 1, 2014, 8:25 AM EDT - U.S. Markets open in 1 hr 5 mins

Recent

% | $
Click the to save as a favorite.

Novadaq Technologies Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • farfignugen21 farfignugen21 Jan 23, 2013 11:19 PM Flag

    ISRG sold 88 NVDQ Firefly units in Q4

    The economics of the 10-yr ISRG JV are not great as many have learned - ISRG got a sweetheart deal - not much more than OEM cost for the Firefly equip and $200-250 to NVDQ on consumables. Nothing like what NVDQ makes going direct or w/ KCI/Lifecell. That said, benefit is the technology gets widely distributed and surgeons get familiarity with it for use in SPYElite + Pinpoint which is great.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • andersongordon@ymail.com andersongordon Jan 24, 2013 6:20 AM Flag

      How solid are your numbers on "cost for the Firefly equipment" and consumables? I haven't been able to find them anywhere. Also the "10-year" deal started when and is there any covenant to renegotiate shared compensation at its close? You are the first one who seems to have access to this information. Thanks for posting it and I look forward to any further revelations/discussions on the details.
      GSA

      Sentiment: Strong Buy

      • 1 Reply to andersongordon
      • OEM and consummable terms of ISRG deal are avail from analyst reports and from the co. They are 2+ yrs into a 10-yr agreement with ISRG. Dont believe terms are renegotiable, but not 100% on that. Deal is certainly profitable but not hugely so on OEM side and $200-250 on kits. But the benefit of the tech being validated by ISRG, widely distributed and gaining familiarity with surgeons/hospitals is incalculable, plus ISRG will eventually have to re-up given how integral Firefly is becoming to DaVinci.

 
NVDQ
15.34-0.83(-5.13%)Jul 31 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.